Kazia Therapeutics’ Two Paxalisib Abstracts Accepted for 2026 Breast Cancer Symposium
The abstracts will explore paxalisib’s tumor and immune reprogramming activity.
Related stories
Amazon rises 3.9%, Alphabet gains 2.2% after Anthropic loss narrows
Amazon shares rose 3.9% and Alphabet shares gained 2.2% after Anthropic's third-quarter net loss narrowed from the prior quarter.
M impact | EQUITY | Nov 02, 2026, 02:45 PM UTC
American Airlines, Alaska Air and United rise
American Airlines shares rose 4.1%, Alaska Air rose 5.9, and United Airlines rose 5.1%.
M impact | EQUITY | Nov 02, 2026, 02:44 PM UTC
U.S. Airline Shares Rise as Crude Oil Falls More Than 6%
M impact | EQUITY | Nov 02, 2026, 02:44 PM UTC
NAPCO Shares Fall 17.2% After Q1 Revenue Miss
M impact | EQUITY | Nov 02, 2026, 02:43 PM UTC
German Traffic Systems Shares on Track for Worst Day in 25 Years After Outlook Cut
M impact | EQUITY | Nov 02, 2026, 02:43 PM UTC
Kosmos Energy shares fall 13% after Q3 revenue miss
Kosmos Energy shares are down 13% after the company missed revenue expectations for the third quarter.
M impact | EQUITY | Nov 02, 2026, 02:43 PM UTC